Peter Veng-Pedersen
University of Iowa
College of Pharmacy
115 S. Grand Ave.
Iowa City
Name/email consistency: high
- Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy. Rosebraugh, M., Widness, J.A., Veng-Pedersen, P. Drug Metab. Dispos. (2011)
- Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin. Veng-Pedersen, P., Freise, K.J., Schmidt, R.L., Widness, J.A. J. Pharm. Pharmacol. (2008)
- Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation. Veng-Pedersen, P., Chapel, S., Al-Huniti, N.H., Schmidt, R.L., Sedars, E.M., Hohl, R.J., Widness, J.A. Biopharm. Drug. Dispos (2004)
- A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheep. Veng-Pedersen, P., Chapel, S., Al-Huniti, N.H., Schmidt, R.L., Sedars, E.M., Hohl, R.J., Widness, J.A. J. Pharmacol. Exp. Ther. (2003)
- An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. Veng-Pedersen, P., Chapel, S., Schmidt, R.L., Al-Huniti, N.H., Cook, R.T., Widness, J.A. Pharm. Res. (2002)
- Noncompartmentally-based pharmacokinetic modeling. Veng-Pedersen, P. Adv. Drug Deliv. Rev. (2001)
- Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach. Veng-Pedersen, P., Gobburu, J.V., Meyer, M.C., Straughn, A.B. Biopharm. Drug. Dispos (2000)
- Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA). Veng-Pedersen, P., Hong, S.S., Widness, J.A., Schmidt, R.L. Pharm. Res. (1998)









